Christopher Peetz
CIK: 0001614740
Transaction Breakdown
High conviction signal
Position reduction
Derivative conversions
Compensation grants
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Discretionary Trading P&L
Holdings
Transaction History (52 total)
- Oct 6, 2026MIRM
Mirum Pharmaceuticals, Inc.
Exercise(M)Direct5.3K shares at avg. $19.19$102K - Oct 6, 2026MIRM
Mirum Pharmaceuticals, Inc.
Exercise(M)Direct6.9K shares at avg. $15.87$109K - Sep 1, 2026MIRM
Mirum Pharmaceuticals, Inc.
Sale(S)Direct8.3K shares at avg. $98.08$815K - Sep 1, 2026MIRM
Mirum Pharmaceuticals, Inc.
Sale(S)Direct21.7K shares at avg. $98.91$2.1M - Sep 1, 2026MIRM
Mirum Pharmaceuticals, Inc.
Exercise(M)Direct30K shares at avg. $2.94$88K - Aug 10, 2026MIRM
Mirum Pharmaceuticals, Inc.
Sale(S)Direct11.7K shares at avg. $98.51$1.2M - Aug 10, 2026MIRM
Mirum Pharmaceuticals, Inc.
Sale(S)Direct2.3K shares at avg. $100.14$230K - Aug 10, 2026MIRM
Mirum Pharmaceuticals, Inc.
Exercise(M)Direct20K shares at avg. $2.94$59K - Aug 10, 2026MIRM
Mirum Pharmaceuticals, Inc.
Sale(S)Direct6K shares at avg. $99.25$597K - Jul 15, 2026ARQT
Arcutis Biotherapeutics, Inc.
Award(A)Direct4.3K shares- - Jul 6, 2026MIRM
Mirum Pharmaceuticals, Inc.
Sale(S)Direct1.7K shares at avg. $124.79$213K - Jul 6, 2026MIRM
Mirum Pharmaceuticals, Inc.
Sale(S)Direct2K shares at avg. $123.74$244K - Jul 6, 2026MIRM
Mirum Pharmaceuticals, Inc.
Sale(S)Direct4.2K shares at avg. $122.34$512K - Jul 6, 2026MIRM
Mirum Pharmaceuticals, Inc.
Sale(S)Direct12.1K shares at avg. $121.65$1.5M - Jul 6, 2026MIRM
Mirum Pharmaceuticals, Inc.
Exercise(M)Direct20K shares at avg. $2.94$59K - Jun 1, 2026MIRM
Mirum Pharmaceuticals, Inc.
Sale(S)Direct883 shares at avg. $99.66$88K - Jun 1, 2026MIRM
Mirum Pharmaceuticals, Inc.
Sale(S)Direct1K shares at avg. $98.20$100K - Jun 1, 2026MIRM
Mirum Pharmaceuticals, Inc.
Sale(S)Direct6.9K shares at avg. $96.15$666K - Jun 1, 2026MIRM
Mirum Pharmaceuticals, Inc.
Sale(S)Direct16.6K shares at avg. $95.34$1.6M - Jun 1, 2026MIRM
Mirum Pharmaceuticals, Inc.
Sale(S)Direct2.6K shares at avg. $94.64$246K - Jun 1, 2026MIRM
Mirum Pharmaceuticals, Inc.
Exercise(M)Direct30K shares at avg. $2.94$88K - Jun 1, 2026MIRM
Mirum Pharmaceuticals, Inc.
Sale(S)Direct2K shares at avg. $97.56$192K - Mar 16, 2026MIRM
Mirum Pharmaceuticals, Inc.
Sale(S)Direct41K shares at avg. $91.98$3.8M - Mar 15, 2026MIRM
Mirum Pharmaceuticals, Inc.
Exercise(M)Direct50K shares- - Mar 15, 2026MIRM
Mirum Pharmaceuticals, Inc.
Exercise(M)Direct25K shares-
| Type | Shares | Price | Ownership | |||
|---|---|---|---|---|---|---|
| Oct 6, 2026 |  MIRM Mirum Pharmaceuticals, Inc. | Exercise(M) | 5,305 | $19.19 | $101,803 | Direct |
| Oct 6, 2026 | MIRM Mirum Pharmaceuticals, Inc. | Exercise(M) | 6,892 | $15.87 | $109,376 | Direct |
| Sep 1, 2026 | MIRM Mirum Pharmaceuticals, Inc. | Sale(S) | 8,312 | $98.08 | $815,241 | Direct |
| Sep 1, 2026 | MIRM Mirum Pharmaceuticals, Inc. | Sale(S) | 21,688 | $98.91 | $2,145,160 | Direct |
| Sep 1, 2026 | MIRM Mirum Pharmaceuticals, Inc. | Exercise(M) | 30,000 | $2.94 | $88,080 | Direct |
| Aug 10, 2026 | MIRM Mirum Pharmaceuticals, Inc. | Sale(S) | 11,683 | $98.51 | $1,150,892 | Direct |
| Aug 10, 2026 | MIRM Mirum Pharmaceuticals, Inc. | Sale(S) | 2,300 | $100.14 | $230,322 | Direct |
| Aug 10, 2026 | MIRM Mirum Pharmaceuticals, Inc. | Exercise(M) | 20,000 | $2.94 | $58,720 | Direct |
| Aug 10, 2026 | MIRM Mirum Pharmaceuticals, Inc. | Sale(S) | 6,017 | $99.25 | $597,187 | Direct |
| Jul 15, 2026 |  ARQT Arcutis Biotherapeutics, Inc. | Award(A) | 4,315 | - | $0 | Direct |
| Jul 6, 2026 | MIRM Mirum Pharmaceuticals, Inc. | Sale(S) | 1,710 | $124.79 | $213,391 | Direct |
| Jul 6, 2026 | MIRM Mirum Pharmaceuticals, Inc. | Sale(S) | 1,975 | $123.74 | $244,387 | Direct |
| Jul 6, 2026 | MIRM Mirum Pharmaceuticals, Inc. | Sale(S) | 4,181 | $122.34 | $511,504 | Direct |
| Jul 6, 2026 | MIRM Mirum Pharmaceuticals, Inc. | Sale(S) | 12,134 | $121.65 | $1,476,101 | Direct |
| Jul 6, 2026 | MIRM Mirum Pharmaceuticals, Inc. | Exercise(M) | 20,000 | $2.94 | $58,720 | Direct |
| Jun 1, 2026 | MIRM Mirum Pharmaceuticals, Inc. | Sale(S) | 883 | $99.66 | $88,000 | Direct |
| Jun 1, 2026 | MIRM Mirum Pharmaceuticals, Inc. | Sale(S) | 1,021 | $98.20 | $100,262 | Direct |
| Jun 1, 2026 | MIRM Mirum Pharmaceuticals, Inc. | Sale(S) | 6,926 | $96.15 | $665,935 | Direct |
| Jun 1, 2026 | MIRM Mirum Pharmaceuticals, Inc. | Sale(S) | 16,595 | $95.34 | $1,582,167 | Direct |
| Jun 1, 2026 | MIRM Mirum Pharmaceuticals, Inc. | Sale(S) | 2,602 | $94.64 | $246,253 | Direct |
| Jun 1, 2026 | MIRM Mirum Pharmaceuticals, Inc. | Exercise(M) | 30,000 | $2.94 | $88,080 | Direct |
| Jun 1, 2026 | MIRM Mirum Pharmaceuticals, Inc. | Sale(S) | 1,973 | $97.56 | $192,486 | Direct |
| Mar 16, 2026 | MIRM Mirum Pharmaceuticals, Inc. | Sale(S) | 40,985 | $91.98 | $3,769,714 | Direct |
| Mar 15, 2026 | MIRM Mirum Pharmaceuticals, Inc. | Exercise(M) | 50,000 | - | $0 | Direct |
| Mar 15, 2026 | MIRM Mirum Pharmaceuticals, Inc. | Exercise(M) | 25,000 | - | $0 | Direct |
1-25 of 52 transactions
About Peetz Christopher
Peetz Christopher (SEC CIK 0001614740) files insider reports with the SEC as CHIEF EXECUTIVE OFFICER of Mirum Pharmaceuticals, Inc. (MIRM) and Director of Arcutis Biotherapeutics, Inc. (ARQT).
Signal8 holds 23 ownership filings by Peetz Christopher (1 Form 3, 22 Form 4), filed between Nov 14, 2024 and Oct 6, 2026. Those filings report 52 transactions, from Nov 8, 2024 to Oct 6, 2026. Signal8's Form 4 history starts in Sep 2024.
The business address on Peetz Christopher's filings is in FOSTER CITY, CA.
Recent filings by Peetz Christopher
- Oct 6, 2026: Option exercises of MIRM shares (2 lines, Form 4, code M).
- Sep 1, 2026: Open-market sales of MIRM shares (2 lines, Form 4, code S).
- Sep 1, 2026: Option exercise of MIRM shares (Form 4, code M).
- Aug 10, 2026: Open-market sales of MIRM shares (2 lines, Form 4, code S).
- Aug 10, 2026: Option exercise of MIRM shares (Form 4, code M).
Other insiders filing for Mirum Pharmaceuticals, Inc. (MIRM)
- Howe Jolanda, SVP, GLOBAL CONTROLLER
- Myers Robert Paul, Chief Medical Officer
- BJERKHOLT ERIC, CHIEF FINANCIAL OFFICER
- Walbert Timothy P, Director
- Cardon Lon, Director
- Ramasastry Saira, Director